Literature DB >> 31435951

Improved aftercare in LVAD patients: Development and feasibility of a smartphone application as a first step for telemonitoring.

Thomas Schmidt1,2, Philipp Mewes1,3, Jan-Dirk Hoffmann1, Frerk Müller-von Aschwege4, Jenny I Glitza4, Jan D Schmitto5, Sebastian Schulte-Eistrup1, Jürgen R Sindermann1, Nils Reiss1.   

Abstract

For the success of the treatment with a left ventricular assist device (LVAD), both adequate self-management by the patient and an optimum level of support from the implanting hospital are crucial. A smartphone application has recently been developed within the framework of a European research project for the close monitoring of LVAD patients in order to improve upon their current aftercare situation. Using this new tool, different relevant parameters (eg, weight, international normalized ratio [INR], medication, LVAD parameters, symptoms, and photos of the driveline exit) can be sent daily or as required to a corresponding clinical application at the hospital for evaluation. The objective of this study was to monitor the functionality, acceptance, and usability of this smartphone application in LVAD patients. Prospective single-center study: in total, 13 patients (60 ± 7 years, 92% male, 1027 ± 653 days after LVAD implantation) were requested to test the application for approx. 4 weeks. At the end of the study, all entered data were evaluated and the patients were questioned regarding the acceptance and the usability. During the study period of mean 34 ± 8 days, a total of 453 data records (mean 35 ± 7 per patient) arrived at the hospital. In addition, a total of 19 photos of the driveline exit site were also sent via smartphone. The clinical application registered a total of 160 conspicuities. These comprised 126 INR deviations (target range 2.3-2.8) and 34 symptoms (mainly nosebleeds). The smartphone application functioned reliably, was well received by the patients and was graded highly for acceptance and usability. The results show that smartphone applications can definitely be used to improve aftercare in LVAD therapy in selected patients. Long-term studies are now needed to investigate the extent to which complications can be prevented, healthcare costs reduced, and quality of life increased.
© 2019 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Keywords:  aftercare; heart failure; left ventricular assist device; quality of life; smartphone application; telemonitoring

Mesh:

Year:  2019        PMID: 31435951     DOI: 10.1111/aor.13560

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  6 in total

1.  Permanent Implantable Cardiac Support Systems.

Authors:  Jan F Gummert; Axel Haverich; Jan D Schmitto; Evgenij Potapov; René Schramm; Volkmar Falk
Journal:  Dtsch Arztebl Int       Date:  2019-12-13       Impact factor: 5.594

2.  Psychological difficulties of LVAD patients and caregivers: A follow up over one year from discharge.

Authors:  Silvia Rossi Ferrario; Anna Panzeri; Massimo Pistono
Journal:  Artif Organs       Date:  2021-09-29       Impact factor: 2.663

3.  VAD Patients' Perception of Potential Telemedicine Support.

Authors:  Thomas Berg; Carina Benstoem; Ajay K Moza
Journal:  Int J Environ Res Public Health       Date:  2022-03-22       Impact factor: 3.390

4.  A picture is worth a thousand words: exploring the roles of caregivers and the home environment of ventricular assist device patients.

Authors:  Martha A Abshire; Julie T Bidwell; Noelle Pavlovic; Lyndsay DeGroot; Dimitra Mammos; Luke Larsen; Svetlana Bautista; Patricia M Davidson
Journal:  Eur J Cardiovasc Nurs       Date:  2021-11-28       Impact factor: 3.593

5.  Commentary: Moving forward, looking back: Lessons from coronavirus disease 2019 (COVID-19) for preparedness in advanced heart failure programs.

Authors:  Scott C Silvestry
Journal:  J Thorac Cardiovasc Surg       Date:  2020-09-09       Impact factor: 5.209

Review 6.  Out of hospital management of LVAD patients during COVID-19 outbreak.

Authors:  Silvia Mariani; Jasmin S Hanke; Günes Dogan; Jan D Schmitto
Journal:  Artif Organs       Date:  2020-07-19       Impact factor: 2.663

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.